Correlation Between Jinhe Biotechnology and Shenzhen Silver

Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and Shenzhen Silver at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and Shenzhen Silver into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jinhe Biotechnology Co and Shenzhen Silver Basis, you can compare the effects of market volatilities on Jinhe Biotechnology and Shenzhen Silver and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of Shenzhen Silver. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and Shenzhen Silver.

Diversification Opportunities for Jinhe Biotechnology and Shenzhen Silver

0.47

Correlation Coefficient

Jinhe Biotechnology  Shenzhen Silver

Very weak diversification

The 3 months correlation between Jinhe and Shenzhen is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and Shenzhen Silver Basis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Silver Basis and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with Shenzhen Silver. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Silver Basis has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and Shenzhen Silver go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and Shenzhen Silver

Assuming the 90 days trading horizon Jinhe Biotechnology Co is expected to under-perform the Shenzhen Silver. But the stock apears to be less risky and, when comparing its historical volatility, Jinhe Biotechnology Co is 2.09 times less risky than Shenzhen Silver. The stock trades about 0.0 of its potential returns per unit of risk. The Shenzhen Silver Basis is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  765.00  in Shenzhen Silver Basis on September 28, 2024 and sell it today you would earn a total of  208.00  from holding Shenzhen Silver Basis or generate 27.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Jinhe Biotechnology Co  vs.  Shenzhen Silver Basis

Jinhe Biotechnology

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Shenzhen Silver Basis

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shenzhen Silver Basis has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Shenzhen Silver is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Jinhe Biotechnology and Shenzhen Silver

The main advantage of trading using opposite Jinhe Biotechnology and Shenzhen Silver positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, Shenzhen Silver can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Silver will offset losses from the drop in Shenzhen Silver's long position.

The idea behind Jinhe Biotechnology Co and Shenzhen Silver Basis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.